Your health starts in your genes

bt_bb_section_bottom_section_coverage_image

AMS Laborator Genetic facilitates access to your unique genetic information so you can take control of your health.
Being healthy means being informed!

How testing helps?

Eating right, exercising, and getting routine checkups (like an annual well-woman visit) are great for the average person. But what if you’re not average? Your genes can tell you if there’s something more you should be doing to improve your health or stay healthy, including:

Lifestyle changes
Early action to prevent the onset of disease
More frequent or earlier screenings for a particular condition or disease

Why should you test?

1 in 6 healthy adults is at increased risk for a serious health condition due to their genetics—and probably doesn't know it.¹

When it comes to your health, one size doesn’t fit all!

77% of people say they’d likely take a test if it would help them develop a personalized health plan.¹ There’s nothing more personal than your genes.

Invest in your health!

From green juice to home workout equipment, you’re already prioritizing things that support your health.

But did you know that genetic testing can help you make the most of those investments by helping you decide where you may need to focus your health habits?

Genetic testing can tell you if you could benefit from:

Changing your lifestyle, diet, or exercise routine

Seeing a specialist

Starting or stopping certain treatments, medications, or supplements

Increasing medical screenings so you can act early, when treatment is most effective

Hereditary genetic screening panels

Teste

Test

Details

Biological sample

Method

Hereditary Screening Comprehensive Panel

Hereditary Screening Comprehensive Panel The panel covers 154 genes associated with increased risk for the most common hereditary cancers. This panel includes genes with strong evidence as well as candidate genes with recent association but which may have low or unclear risk. The panel maximizes the chance of identifying disease-causing variants and provides extensive analysis of potential cancer risks from candidate genes
Genes:
ABRAXAS1, AIP, AKT1, ALK, ANKRD26, APC, ATM, ATR, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CASR, CDC73, CDH1, CDK4, CDKN1B, CDKN1C, CDKN2A, CEBPA, CEP57, CHEK2, CTC1, CTNNA1, CTRC, CYLD, DDB2, DDX41, DICER1, DIS3L2, DKC1, EGFR, EGLN1, ELANE, ENG, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, EXO1, EXT1, EXT2, EZH2, FAN1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GALNT12, GATA2, GEN1, GPC3, GREM1, HOXB13, HRAS, IKZF1, KIF1B, KIT, LZTR1, MAX, MC1R, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NHP2, NOP10, NTHL1, PALB2, PALLD, PAX5, PDGFRA, PHOX2B, PIK3CA, PMS2, POLD1, POLE, POLH, POT1, PRKAR1A, PRSS1, PTCH1, PTCH2, PTEN, RAD50, RAD51C, RAD51D, RB1, RECQL, RECQL4, REST, RET, RHBDF2, RNF43, RPS20, RUNX1, SAMD9L, SBDS, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLC45A2, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, SPINK1, SRP72, STK11, SUFU, TERC, TERT, TGFBR1, TINF2, TMEM127, TP53, TRIP13, TSC1, TSC2, TYR, VHL, WRAP53, WRN, WT1, XPA, XPC, XRCC2 ( 154 genes )
Technical data:
Typical coverage for coding sequences: 99% at ≥ 50x
Sequencing; Del/Dup; does not report VUS
Single resolution del/dup analysis for all genes
BRCA2: The Portuguese founder mutation
PTEN: Promoter region
TP53: Promoter region
CDKN2A: p14ARF and p16 protein products
PMS2: Analysis includes exons 1-5 and 12-15
TERT: Promoter region
GREM1: Promoter region Saliva/
blood NGS

Saliva/ blood

NGS

Reference

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020